Alfonso Quintás Cardama – Biography

Last update: February 24, 2026

Executive profile

Alfonso was Head Clinical Development, Cell Therapies at GSK, and Global Clinical Leader Clinical Development CTL019 Program at Novartis. Alfonso Quintás Cardama joined Foghorn Therapeutics in 2023.

Alfonso Quintás Cardama is currently

Create your alert
to follow the career of Alfonso Quintás Cardama.

More about Alfonso Quintás Cardama

Do you need to know more about Alfonso Quintás Cardama? More results.

Participate
Social media

The colleagues of Alfonso Quintás Cardama

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Alfonso Quintás Cardama has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Alfonso Quintás Cardama.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard,
and ask for Alfonso Quintás Cardama.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board